MRA Pilot Award
Funds high-risk melanoma proof-of-concept efforts through grants for high-impact experimental ideas.
The Melanoma Research Alliance (MRA) is the world's largest private nonprofit funder of melanoma research, having invested more than $200 million across over 500 grant awards since its founding in 2007. The General RFP is MRA's flagship annual funding cycle, supporting pre-clinical, translational, and early clinical research with the potential to produce high-impact, near-term advances in melanoma…
High-risk, high-reward proof-of-concept melanoma research requiring minimal preliminary data, including acral and uveal melanoma sub-tracks, open to US, UK, and Israel institutions.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline